Loading...
Docoh

Novartis (NVS)

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

NVS stock data

Calendar

26 Apr 22
17 May 22
31 Dec 22
Quarter (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
8.6% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 1093 1028 +6.3%
Opened positions 153 55 +178.2%
Closed positions 88 93 -5.4%
Increased positions 313 353 -11.3%
Reduced positions 446 383 +16.4%
13F shares Current Prev Q Change
Total value 18.33B 17.84B +2.7%
Total shares 209.58M 218.15M -3.9%
Total puts 1.39M 999.8K +38.6%
Total calls 4.79M 4.55M +5.3%
Total put/call ratio 0.3 0.2 +31.6%
Largest owners Shares Value Change
Dodge & Cox 28.25M $2.47B -3.5%
Primecap Management 18.17M $1.59B -4.7%
Loomis Sayles & Co L P 17.89M $1.57B -5.5%
Fisher Asset Management 10.38M $908.35M +0.8%
BEN Franklin Resources 9.14M $799.55M +34.8%
BAC Bank Of America 7.79M $681.24M -15.5%
Boston Partners 4.68M $409.19M +6.7%
Charles Schwab Investment Management 4.21M $367.87M +2.2%
UBS UBS Group AG - Registered Shares 4.18M $365.53M -7.3%
Wellington Management 4.1M $358.32M -2.8%
Largest transactions Shares Bought/sold Change
Aristotle Capital Management 562.21K -7.57M -93.1%
BEN Franklin Resources 9.14M +2.36M +34.8%
WFC Wells Fargo & Co. 3.17M -2.15M -40.4%
D. E. Shaw & Co. 1.82M +1.79M +6907.7%
BAC Bank Of America 7.79M -1.42M -15.5%
Loomis Sayles & Co L P 17.89M -1.05M -5.5%
Dodge & Cox 28.25M -1.02M -3.5%
Dimensional Fund Advisors 3.87M +1M +35.0%
Primecap Management 18.17M -896.06K -4.7%
Two Sigma Advisers 2.87M +772.9K +36.9%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AboveFinancial, additonal, AGMp, allo, Ana, andwaste, Antonio, apparent, appellate, ASCVD, aspart, autoinflammatory, azido, backdrop, banned, BELINDA, Benz, Bergen, bevacizumab, Bladder, BSE, BuechnerB, BulaB, businessp, cacy, Cameroon, candidatesBased, card, Catalyst, cation, ceased, cephalosporin, CGU, chose, cific, Claudia, COI, col, commercializationi, CommitteeSCIENCE, CommitteeT, competitivenessp, Concurrently, consumptione, contraindicated, cor, County, cure, curing, dampened, dangerously, Dayp, dengue, deputy, dermal, developmentsp, Diabetology, disabilityAccelerated, disagreement, disappointing, disclaimer, dMeetingsNumber, EDM, effi, eMeetingsNumber, enjoin, ensovibep, epi, erwise, esophageal, excused, feel, flu, foregoing, formulaStep, Fortum, forwardi, glance, glargine, Gonzalo, graphical, groupAbbvieBiogenGlaxoSmithKlineNovo, groupp, growthp, Gyroscope, Hale, HaleChief, harder, HARMONIA, heat, HeFH, hemolytic, Hepatocellular, HiSCR, HRSA, HS, humidity, hypothetical, IBOR, ID, illustrate, illustration, implementationPatient, impurity, incidenti, incon, indica, Indonesia, infor, inline, inorganic, Interbank, intrinsic, jeopardize, JPsA, Karen, KowalskiChief, landlord, libvatrep, LID, linear, lispro, log, login, longest, LVEF, map, marketsp, mation, mattersp, MAXIMISE, Maze, MetETHICAL, MetStrategic, millionMetGroup, monitoringof, morbidity, MRI, multicounty, mutagen, NaN, Nasopharyngeal, NBIM, NHS, NICE, Nigeria, NordiskRocheAmgen, Nurse, ociperlimab, Officep, OfficerHarry, OIG, Omicron, orderly, oth, oversightDesign, Pakistan, palbociclib, password, PayoutOverall, PAYOUTPayoutThe, performanceAll, performanceAnnual, performanceUnvested, PFS, Pharmacia, placei, PLANAward, poorest, porate, port, Prime, programsi, protease, PSUsGlobal, QR, quent, quiet, rangeFinancial, rash, Rawlinson, redesign, RegulationsExecutive, rem, remanded, replication, resultse, revisit, Rob, RSUsRetirement, Rwanda, RWE, Sandozi, sBLA, scarcity, Scemblix, SDOE, setsProvide, settingFinancial, sincerest, sistent, SLB, softer, spe, stay, stretch, Subse, Subtotal, sugar, SUNRISE, SUNSHINE, surpassed, swelling, switching, Symposium, synergistic, targetNet, targetse, targetThreshold, targetTSR, teamwork, terminology, tetraxetan, throughput, TIGIT, topline, TPRM, transcription, treasurer, trendsp, TSRTarget, UCB, unaffected, undermine, uremic, urothelial, utmost, vacated, valuee, vehiclePerformance, Vicki, vide, vipivotide, wake, weak, workplace, XBRL, yearslong, Zinacef, Zinnat
Removed: adalimumab, Advair, Afinitor, agreementAll, ALS, Amazon, amyotrophic, angiomyolipoma, antibacterial, anticompetitive, antiviral, ARB, asciminib, asserting, assetsTaxesCapital, assuming, astrocytoma, BaertChief, Bahrain, Belgian, Berkeley, biggest, bind, blocker, brain, Brentford, Britain, bromide, capmatinib, Carnegie, Carolina, centralize, CFTR, chairmanship, Chapel, CHFAnnual, companion, compelling, computation, congressional, conjugation, considerable, Conversely, COPD, CRL, cultural, currenciesThe, cyclepayout, Daimler, DatarA, DatarE, deactivate, declared, Delta, derecognized, desire, deviation, discontinuation, discontinue, discouraging, dismutase, dispersible, Disperz, donation, driver, drove, dysfunction, EMI, enabled, enoxaparin, etanercept, evolution, exemestane, extracted, fevipiprant, fluticasone, formed, genetically, Georgia, giant, hcl, Heineken, hereinafter, Hill, Hudson, hydrochlorothiazide, ICF, immigration, inconsistent, indacaterol, indemnify, inhaled, insight, instability, instruct, interval, intervention, intrathecal, investmentsExecutive, journey, KPIT, lactam, Lafarge, leave, legacy, Les, liver, Lotrel, Luc, mCRPC, Middlesex, misconductAll, Momenta, mometasone, mTOR, Music, neurological, nil, nominating, nuclear, observing, obstructive, OfficerShannon, OfficerSteven, onward, ordering, organ, outcomefor, outperform, Outperformance, pace, Paul, PAYOUTPayoutOverall, pembrolizumab, performanceAward, PLANSGrant, PlantaC, PlantaE, potentiator, preliminary, promotional, propionate, PSUsTarget, pulmonary, reasonNo, reinforcing, reorganize, Rett, rheumatoid, RSUsIf, RTT, salaryLTRPP, salaryPayout, salmeterol, scheme, SEGA, segregation, sharply, Sherpany, shift, shifted, simplification, Solvay, space, spartalizumab, speed, Stanford, Starlix, statistically, STOXX, Stryker, subependymal, sublicensed, succeed, superoxide, supplanted, swing, Tabular, tendered, Tennessee, tisagenlecleucel, TNF, tool, transplantation, triple, Trump, TSC, turned, undone, unfair, uniform, unresolved, USAN, validly, Valturna, var, vector, Votubia, WACC, wave, worsened, worth, yearsEquity, yield